Flavivirus infections alter the skin microbiome of mice to increase the production of a sweet-smelling compound that attracts the viruses’ insect vectors, a study finds.

Randomized, controlled research conducted in an Indonesian city confirms the reduction in cases seen with previous observational work.

By avoiding the production of antibodies, something vaccines ordinarily induce, the immunization sidesteps the problem of antibody-dependent enhancement, which can amplify infection by a similar virus and is known to occur with dengue and Zika.

Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.

Cases of dengue were greatly reduced in areas of a city where Wolbachia-infected mosquitos were released, according to preliminary data from a field study.

A study of Nicaraguan children links prior Zika virus infection with aggravated dengue fever symptoms.

There have been no reports of health or environmental harm in other locations where genetically modified mosquitoes have been introduced over the last decade.

Through groundbreaking studies on dengue and efforts to build scientific infrastructure in Latin America, the University of California, Berkeley, professor has bridged research with its benefits to society.

TAK-003 appears to avoid the safety issues seen with an existing vaccine, but experts say a longer evaluation is needed.

Researchers use two techniques—Wolbachia infection and irradiation—to suppress reproduction in populations of Asian tiger mosquitoes at two study sites in China.

Children were 38 percent less likely to show signs of Zika infection if they had previously had dengue.

Climate change may open up new habitats suitable for the virus’s spread.

The drugs’ disruption of the microbiome makes a subsequent flavivirus infection more severe.

The drug may worsen future infections for people who haven't already been exposed to the virus.

A single receptor on natural killer cells recognizes an amino acid sequence conserved across Zika, dengue, and related pathogens.

The US government has approved the deployment of the lab-raised insects to eliminate the Zika- and dengue-transmitting Asian tiger mosquito.

The EPA is now in charge of regulating the use of Oxitec’s strain of Aedes aegypti, genetically engineered to reduce populations of the insects.

Mice receiving the treatment produced their own monoclonal antibodies and survived infection with the life-threatening pathogen Pseudomonas aeruginosa.

A memory B cell response to Zika virus in dengue-infected patients produced antibodies that were poorly neutralizing in vitro and instead enhanced infection.